No recent analyst price targets found for PTH.
Latest News for PTH
Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism
Trial Designed to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SEP-479 in Healthy Volunteers
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for PTH.
Senate Trading
No Senate trades found for PTH.
U.S. House Trading
No House trades found for PTH.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.